Last updated Nov 17, 2026. 972 unique records for "thymosin alpha-1" OR "thymosin alpha 1" OR "thymosin α1" OR "thymosin α-1" OR thymalfasin OR "thymosin A1" OR "Thymosin-alpha1". 2026 is a partial year. Brand names that appear in some records are not used on this page. Regulatory status outside the United States is not presented here as a use claim. Source on PubMed
RC-TA1 · Immune Signaling Research
RC-TA1
Immune Signaling Research
Vial sizes for laboratory supply, not a protocol.
Key specifications
Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.
- Catalog title
- RC-TA1 | Immune Signaling Research
- Research focus
- Immune Signaling Research
- Also described as
- Thymosin alpha-1 · thymalfasin
- Format
- Lyophilized research peptide
- Catalog status
- In stock (public listing)
- Presentations
- 10 mg vial (catalog presentation)Catalog sizes, not a protocol
- Molecular formula
- C129H215N33O55PubChem CID 16130571
- Molecular weight
- 3,108.3PubChem average; exact mass 3,107.5074829
- Receptor context
- Thymus-derived 28-residue, N-terminally acetylated peptide (synthetic form also called thymalfasin); immune-signaling research contextLiterature description; research context only
- Sequence
- Not reproduced hereSee primary literature / PubChem
- Researcher access
- Sign-in required to view pricing
- PubMed records
- 972 uniqueQuery above, Nov 17, 2026
Catalog notes & use limitations
Research-catalog framing only. This section does not describe effects in people or study outcomes.
Catalog notes
Listed under Immune Signaling Research
RC-TA1 appears in the PEPTIDEA™ Immune & Inflammation Signaling Research collection with RC-KPV and RU-L37.
Synthetic thymosin alpha-1 / thymalfasin
The catalog identity is thymosin alpha-1. The synthetic form is also called thymalfasin in the literature. This page does not present regulatory status or brand names as a use claim.
Single catalog presentation
The public listing is a simple product. The 10 mg vial size is inferred from SKU RC-409-10 and is a presentation of the research material, not a protocol.
Use limitations
Research use only
Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.
No outcome or dosing information
This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.
Confirm details from primary sources
Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.
Specifications
Laboratory-catalog and public-chemistry details. Items without a cited source are marked.
| Catalog title | RC-TA1 | Immune Signaling Research |
|---|---|
| Category | Immune Signaling Research (Immune & Inflammation Signaling Research) |
| Associated names | Thymosin alpha-1; thymosin α1; thymalfasin |
| Format | Lyophilized research peptide |
| Public catalog status | In stock (as of Nov 17, 2026) |
| Catalog presentations | 10 mg vial (catalog presentation) — sizes of the research material, not a use protocol |
| Molecular formula | C129H215N33O55 (PubChem CID 16130571, retrieved Nov 17, 2026) |
| Molecular weight | 3,108.3 (PubChem average; exact mass 3,107.5074829) |
| InChIKey | NZVYCXVTEHPMHE-ZSUJOUNUSA-N (PubChem) |
| Receptor context | Published papers describe thymosin alpha-1 as a 28-amino-acid, N-terminally acetylated peptide derived from prothymosin α. The synthetic form is also called thymalfasin. That is an identity description, not a use claim. Brand names are not used on this page. |
| Sequence | Not reproduced on this page. See primary literature and the PubChem record. |
| Pricing | Visible after researcher sign-in |
Research literature
These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.
Low et al.
This paper surveys early thymosin research, including evidence for a family of thymic factors studied in T-cell maturation.
Experimental findings and any clinical-context discussion in the paper are not restated on this page.
McGillis, Hall, and Goldstein
This paper reported circadian-rhythm measurements of thymosin alpha-1 in normal and thymectomized mice.
Concentration findings and any other experimental results in the paper are not reproduced here.
Ancell, Phipps, and Young
This review surveys the published literature on thymosin alpha-1, including laboratory and clinical-research contexts described at the time.
Clinical inferences, protocols, and outcome figures cited in the review are not restated on this page.
Liaw
This paper discusses thymalfasin (thymosin alpha-1) in adults with chronic hepatitis B, as described in the clinical research literature of the time.
Treatment-context language, protocols, and any results in the paper are not reproduced here.
Hoch and Volk
This review surveys the structures of thymosin proteins, including thymosin alpha-1, in a biochemical and structural-biology context.
Structural models and any functional inferences in the review are not restated as results on this page.
Simonova et al.
This review surveys published literature that discusses thymosin alpha-1 in aging-biology research contexts.
Aging-related inferences and any outcome figures cited in the review are not reproduced on this page.
Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query "thymosin alpha-1" OR "thymosin alpha 1" OR "thymosin α1" OR "thymosin α-1" OR thymalfasin OR "thymosin A1" OR "Thymosin-alpha1". Source on PubMed
Storage & handling
General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.
- Handle as a lyophilized research material intended for laboratory use only.
- Store according to the conditions printed on the label and in any compound document provided to approved researchers.
- Protect closed vials from moisture and unnecessary temperature swings.
- If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
- This material is not for human or veterinary use and is not medical advice.
Research Use Only. Not for human or veterinary use. Not medical advice. PEPTIDEA™ is a trademark of Grey Bug LLC.


